-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Heron Therapeutics (NASDAQ:HRTX) Raised to “Buy” at StockNews.com
Heron Therapeutics (NASDAQ:HRTX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $4.00 target price on shares of Heron Therapeutics in a research note on Friday. Get Our Latest Report […]
Heron Therapeutics (NASDAQ:HRTX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $4.00 target price on shares of Heron Therapeutics in a research note on Friday. Get Our Latest Report […]
